CYNTHIA KRAUSS: Open Payments
NPI 1861268229 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 25 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $642
Food & beverage: $562Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Eisai Inc. | 2 | $45 |
| Aveo Pharmaceuticals, Inc. | 1 | $39 |
| Exelixis Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Genmab U.S., Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: ERLEADA, LIBTAYO, CALQUENCE, Lenvima, REBLOZYL, FOTIVDA, CABOMETYX, WELIREG.
Industry payments across TN — which companies pay providers there.
